Perceptive Advisors’s AbbVie ABBV Stock Holding History

Perceptive Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-106,500	Closed	-$19.4M	–	111
2024 Q1	$19.4M	Sell	106,500 -131,500	-55%	-$22.7M	0.34%	63
2023 Q4	$36.9M	Buy	+238,000	New	+$34.7M	0.82%	37
2017 Q2	–	Sell	-380	Closed	-$25K	–	127
2017 Q1	$25K	Buy	+380	New	+$23.9K	﹤0.01%	140
2016 Q3	–	Sell	-1,250	Closed	-$77K	–	193
2016 Q2	$77K	Buy	+1,250	New	+$76.2K	0.01%	151
2014 Q2	–	Sell	-67,000	Closed	-$3.44M	–	118
2014 Q1	$3.44M	Sell	67,000 -283,000	-81%	-$14.3M	0.36%	53
2013 Q4	$18.5M	Buy	+350,000	New	+$17.2M	2.22%	13

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors's ABBV Position: Q2 2024 in Review

Perceptive Advisors sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 106,500 shares — an estimated $19.4M sold.

Perceptive Advisors first reported a position in ABBV in Q4 2013 and held it in 6 quarters. The position peaked at $36.9M in Q4 2023. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

Perceptive Advisors reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
Perceptive Advisors sold 106,500 AbbVie shares in Q2 2024, an estimated $19.4M.
Perceptive Advisors first reported a position in AbbVie in Q4 2013 and held it in 6 quarters.
Perceptive Advisors's AbbVie position peaked at $36.9M in Q4 2023.
3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Perceptive Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.